EMC Instytut Medyczny SA

WSE:EMC Stock Report

Market Cap: zł487.3m

EMC Instytut Medyczny Valuation

Is EMC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Share Price vs Fair Value

What is the Fair Price of EMC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
zł83.84
Fair Value
86.2% undervalued intrinsic discount
0
Number of Analysts

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EMC?

Key metric:

The above table shows the Price to Earnings ratio for EMC. This is calculated by dividing EMC's market cap by their current earnings.
What is EMC's PE Ratio?
PE Ratio40.8x
Earningszł11.95m
Market Capzł487.28m

Price to Earnings Ratio vs Peers

How does EMC's PE Ratio compare to its peers?

The above table shows the PE ratio for EMC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average37.6x
ENE Centrum Medyczne ENEL-MED
87.5xn/azł610.9m
VOX Voxel
17.4x12.3%zł1.5b
NEU NEUCA
23.3x21.8%zł3.8b
SNT Synektik Spólka Akcyjna
22.2x14.4%zł1.9b
EMC EMC Instytut Medyczny
40.8xn/azł487.3m

Price to Earnings Ratio vs Industry

How does EMC's PE Ratio compare vs other companies in the European Healthcare Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
EMC 40.8xIndustry Avg. 19.6xNo. of Companies8PE01020304050+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price to Earnings Ratio vs Fair Ratio

What is EMC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EMC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio40.8x
Fair PE Ration/a

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 08:45
End of Day Share Price 2025/01/31 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

EMC Instytut Medyczny SA is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution